Covered recipient · General Payments record
JALDEEP H DAULAT
Allopathic & Osteopathic Physicians Dermatology MOHS-Micrographic Surgery
General Payments · PY2018–2024
$2,021.33
- Reported across 107 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $266.35 | 14 |
| Education | $177.94 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $242.22 | 5 |
| ABBVIE INC. | $112.18 | 5 |
| UCB, Inc. | $30.91 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $30.15 | 2 |
| Biofrontera Inc. | $14.49 | 2 |
| E.R. Squibb & Sons, L.L.C. | $14.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.32 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103604158 | CMS |
| ABBVIE INC. | $28.59 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103604160 | CMS |
| ABBVIE INC. | $24.90 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103604162 | CMS |
| ABBVIE INC. | $20.42 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103604164 | CMS |
| ABBVIE INC. | $21.95 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103604166 | CMS |
| Biofrontera Inc. | $12.34 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089609884 | CMS |
| Biofrontera Inc. | $2.15 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103323188 | CMS |
| Boston Scientific Corporation | $16.08 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092687699 | CMS |
| Boston Scientific Corporation | $14.07 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092687697 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.34 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101629393 | CMS |
| Janssen Biotech, Inc. | $19.99 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078392363 | CMS |
| Janssen Biotech, Inc. | $94.99 | 04/01/2024 | Education | Undisputed | 01/23/2026 | 1078392513 | CMS |
| Janssen Biotech, Inc. | $27.38 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078390998 | CMS |
| Janssen Biotech, Inc. | $82.95 | 10/30/2024 | Education | Undisputed | 01/23/2026 | 1078389501 | CMS |
| Janssen Biotech, Inc. | $16.91 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078392900 | CMS |
| UCB, Inc. | $30.91 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143128012 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.